Stock 300622 DOCTORGLASSES CHAIN CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Doctorglasses Chain Co.,Ltd.

Equities

300622

CNE100002PH4

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
15.14 CNY -2.57% Intraday chart for Doctorglasses Chain Co.,Ltd. +2.64% -23.65%
Apr. 25 Doctorglasses Chain Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 03 Doctorglasses Chain Co.,Ltd. Proposes Final Dividend for the Year 2023 CI

Summary

  • Overall, the company has poor fundamentals for a medium to long-term investment strategy.
  • From a short-term investment perspective, the company presents a deteriorated fundamental situation

Strengths

  • Its core activity has a significant growth potential and sales are expected to surge, according to Standard & Poor's' forecast. Indeed, those may increase by 55% by 2026.
  • This company will be of major interest to investors in search of a high dividend stock.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • Over the past twelve months, analysts' opinions have been strongly revised upwards.

Weaknesses

  • The company appears highly valued given the size of its balance sheet.
  • For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
  • The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
  • For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
  • For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.

Ratings chart - Surperformance

Sector: Other Specialty Retailers

1st Jan change Capi. Investor Rating ESG Refinitiv
DOCTORGLASSES CHAIN CO.,LTD. Stock Doctorglasses Chain Co.,Ltd.
-23.65% 364M -
NATIONAL VISION HOLDINGS, INC. Stock National Vision Holdings, Inc.
-14.57% 1.4B
C
SYNSAM AB Stock Synsam AB
+15.07% 713M -
JINS HOLDINGS INC. Stock JINS HOLDINGS Inc.
-30.64% 483M -
FORMOSA OPTICAL TECHNOLOGY CO.,LTD. Stock Formosa Optical Technology Co.,Ltd.
+21.86% 188M - -
KITS EYECARE LTD. Stock Kits Eyecare Ltd.
-5.29% 136M -
PARIS MIKI HOLDINGS INC. Stock Paris Miki Holdings Inc.
-23.15% 128M - -
MISTER SPEX SE Stock Mister Spex SE
-4.91% 109M -
SILMÄASEMA OYJ Stock Silmäasema Oyj
+0.33% 92.65M - -
FOCUS POINT HOLDINGS Stock Focus Point Holdings
+2.82% 70.73M -
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
-

Valuation

P/E ratio
EV / Sales
-
Price to Book
Price to Free Cash Flow
-
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
-
4m Target Price Revision
-
4m Revision of opinion
-
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
-
Earnings quality
-

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. 300622 Stock
  4. Ratings Doctorglasses Chain Co.,Ltd.